Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancers (NSCLC) account for 85–90% of all lung cancers. As drug resistance critically impairs chemotherapy effectiveness, there is great need to identify new therapeutic targets. The aims of this study were to investigate the prognostic and therapeutic potential of th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Cancer
Huvudupphovsmän: Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434762/
https://ncbi.nlm.nih.gov/pubmed/32439936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0899-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk